Q1 2022 Holdings
Filed 2022-05-13 | 220 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $1.1M | 40,900 | 0.1% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $1.3M | 54,500 | 0.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $1.6M | 36,500 | 0.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.5M | 69,000 | 0.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $3.5M | 111,700 | 0.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.7M | 22,350 | 0.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.8M | 74,600 | 0.4% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $9.1M | 3,293,000 | 0.6% |
| Avantor Inc(AVTR) | COM | 05352A100 | $17.3M | 512,216 | 1.1% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $19.1M | 111,766 | 1.2% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $27.3M | 607,614 | 1.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $29.8M | 719,482 | 1.9% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $29.8M | 2,405,825 | 1.9% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $33.4M | 582,821 | 2.2% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $35.9M | 126,406 | 2.3% |
| Atricure Inc(ATRC) | COM | 04963C209 | $39.3M | 598,605 | 2.5% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $40.6M | 72,009 | 2.6% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $43.7M | 3,145,293 | 2.8% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $50.5M | 311,500 | 3.3% |
| Centene Corp del(CNC) | COM | 15135B101 | $55.6M | 660,635 | 3.6% |
| Align Technology Inc(ALGN) | COM | 016255101 | $61.6M | 141,351 | 4.0% |
| Caredx Inc(CDNA) | COM | 14167L103 | $85.5M | 2,311,176 | 5.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $120.2M | 4,129,292 | 7.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $146.7M | 2,179,253 | 9.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $173.3M | 3,913,947 | 11.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $200.8M | 1,229,563 | 13.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $300.6M | 953,238 | 19.4% |